Humalog Junior KwikPen
Humalog Junior KwikPen ingredients
| Active ingredient | Strength |
|---|---|
| Insulin Lispro | 100 [iU]/mL |
What Humalog Junior KwikPen is used for
Humalog Junior KwikPen is a specialist medicine (insulin analog). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Humalog Junior KwikPen
- Generic name
- Insulin lispro
- Made by
- Eli Lilly and Company
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Insulin Analog
- FDA approval
- Biologic licence (BLA) BLA020563
- On the US market since
- 2017
Official information
- Humalog Junior KwikPen prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Insulin lispro)
In India
- Insulin lispro: 14 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Humalog Junior KwikPen?
Humalog Junior KwikPen (Insulin lispro) is a specialist medicine made by Eli Lilly and Company, approved by the US FDA.
What are the ingredients of Humalog Junior KwikPen?
Humalog Junior KwikPen contains Insulin Lispro (100 [iU]/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA